Načítá se…
Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy
Following the previously published results of the clinical randomized ZeOxaNMulti trial, we evaluated the potential of the tested product PMA-ZEO (Multizeo Med) in the prevention of chemotherapy-induced side effects (especially peripheral neuropathy) within a 30-month follow-up analysis. The aim was...
Hlavní autoři: | , , , , , , , , , , , |
---|---|
Médium: | Online Článek Text |
Jazyk: | English |
Vydáno: |
Frontiers Media S.A.
2022
|
Témata: | |
On-line přístup: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680527/ https://www.ncbi.nlm.nih.gov/pubmed/36425572 http://dx.doi.org/10.3389/fphar.2022.874028 |